Why Clinicians Don't Report Adverse Drug Events: Qualitative Study

Area of Science:

• Pharmacovigilance and Drug Safety
• Health Informatics
• Qualitative Research Methods

Background:

• Adverse drug events (ADEs) are critical for patient care and safety but are significantly underreported.
• Underreporting hinders effective postmarketing surveillance and quality improvement initiatives.

Purpose of the Study:

• To identify barriers to adverse drug event documentation.
• To determine factors contributing to the underreporting of adverse drug events.

Main Methods:

• Qualitative study utilizing workplace observations and focus groups with diverse healthcare providers.
• Data analysis involved iterative coding, thematic summarization, and workflow diagramming.
• Clinician validation of emerging concepts using real-world clinical cases.

Main Results:

• Observed 65 complex adverse drug events (ADEs) requiring multidisciplinary input over 238 hours.
• Clinicians documented ADEs for continuity of care but not for external reporting.
• Barriers included time constraints and documentation duplication.

Conclusions:

• Existing adverse drug event reporting systems are ill-suited for complex cases and clinical workflows.
• Integrated electronic medical record systems with data reuse and alerts could improve ADE reporting.
• Enhanced systems may capture robust ADE data as a byproduct of safer patient care.